- Tytuł:
- Characterization and management of ERK inhibitor associated dermatologic adverse events: analysis from a nonrandomized trial of ulixertinib for advanced cancers
- Autorzy:
- Źródło:
- Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies. 39(3):785-795
Czasopismo naukowe